Market Cap 555.64B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.82
Forward PE 20.24
Profit Margin 28.46%
Debt to Equity Ratio 0.48
Volume 11,681,200
Avg Vol 8,294,324
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 7%
Beta 0.34
Analysts Strong Sell
Price Target $253.84

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
Pudgeman007
Pudgeman007 Apr. 21 at 10:56 PM
$JNJ This clown has no website! No bio, track record, selling on an E-commerce site. Hey stocktwits he spammed over 100 tickers in the last hour
0 · Reply
dosaman
dosaman Apr. 21 at 10:31 PM
$JNJ when in doubt look at this. We will bounce back.
0 · Reply
MillionDollarSwingTrader
MillionDollarSwingTrader Apr. 21 at 9:40 PM
$JNJ No spam, no fluff, just High-Probability options trades delivered. 7-Day Free Trial!! We are confident in our process. See for yourself: https://whop.com/million-dollar-swing-trader/trader-alerts/
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Apr. 21 at 9:38 PM
💊 $JNJ buyers should watch the Blue Box zone at 227.8–215.8 👀 This pullback looks corrective and could offer the next high-probability buying opportunity before the next leg higher resumes 📈 Don’t chase—wait for the right setup and trade with the trend. Read more: https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area/ #JNJ #Elliottwave #Stocks #Trading #Investing
0 · Reply
MHM7700
MHM7700 Apr. 21 at 8:45 PM
$JNJ 05/01 220p $2.02
0 · Reply
SenefAS
SenefAS Apr. 21 at 8:16 PM
$GMAB Genmab a lot of options tonight… Something is cooking 🤔 $NVO $JNJ
0 · Reply
frontiere
frontiere Apr. 21 at 7:16 PM
$JNJ Johnson & Johnson ref=$226 — NO pstn but maybe would short >239 ? Similar to NVS 👇, a multi-year breakout?
0 · Reply
DDaphne52
DDaphne52 Apr. 21 at 6:32 PM
$JNJ breaking down
0 · Reply
deltax10
deltax10 Apr. 21 at 5:13 PM
$JNJ buy 500 shares at 226, since then going down Officially bag holder 🤣🤣🤣
0 · Reply
RamGuy_949322
RamGuy_949322 Apr. 21 at 4:55 PM
$JNJ good buy here
0 · Reply
Latest News on JNJ
Johnson & Johnson CFO on the company's robotic surgical system

Apr 14, 2026, 10:51 AM EDT - 7 days ago

Johnson & Johnson CFO on the company's robotic surgical system


J&J raises guidance for 2026 on strong start to the year

Apr 14, 2026, 6:55 AM EDT - 7 days ago

J&J raises guidance for 2026 on strong start to the year


J&J's First-Quarter Sales Grow on Cancer-Drug Strength

Apr 14, 2026, 6:20 AM EDT - 7 days ago

J&J's First-Quarter Sales Grow on Cancer-Drug Strength


The Big 3: ORCL, JNJ, SBUX

Mar 19, 2026, 1:00 PM EDT - 4 weeks ago

The Big 3: ORCL, JNJ, SBUX

ORCL SBUX


US FDA approves J&J's oral psoriasis pill

Mar 18, 2026, 8:31 AM EDT - 4 weeks ago

US FDA approves J&J's oral psoriasis pill


US FDA approves JNJ's blood cancer drug

Mar 5, 2026, 2:21 PM EST - 6 weeks ago

US FDA approves JNJ's blood cancer drug


Does JNJ Stock Still Offer Value?

Feb 23, 2026, 11:35 AM EST - 2 months ago

Does JNJ Stock Still Offer Value?


Bayer files lawsuit against Johnson & Johnson, Janssen Biotech

Feb 23, 2026, 10:43 AM EST - 2 months ago

Bayer files lawsuit against Johnson & Johnson, Janssen Biotech


Pudgeman007
Pudgeman007 Apr. 21 at 10:56 PM
$JNJ This clown has no website! No bio, track record, selling on an E-commerce site. Hey stocktwits he spammed over 100 tickers in the last hour
0 · Reply
dosaman
dosaman Apr. 21 at 10:31 PM
$JNJ when in doubt look at this. We will bounce back.
0 · Reply
MillionDollarSwingTrader
MillionDollarSwingTrader Apr. 21 at 9:40 PM
$JNJ No spam, no fluff, just High-Probability options trades delivered. 7-Day Free Trial!! We are confident in our process. See for yourself: https://whop.com/million-dollar-swing-trader/trader-alerts/
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Apr. 21 at 9:38 PM
💊 $JNJ buyers should watch the Blue Box zone at 227.8–215.8 👀 This pullback looks corrective and could offer the next high-probability buying opportunity before the next leg higher resumes 📈 Don’t chase—wait for the right setup and trade with the trend. Read more: https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area/ #JNJ #Elliottwave #Stocks #Trading #Investing
0 · Reply
MHM7700
MHM7700 Apr. 21 at 8:45 PM
$JNJ 05/01 220p $2.02
0 · Reply
SenefAS
SenefAS Apr. 21 at 8:16 PM
$GMAB Genmab a lot of options tonight… Something is cooking 🤔 $NVO $JNJ
0 · Reply
frontiere
frontiere Apr. 21 at 7:16 PM
$JNJ Johnson & Johnson ref=$226 — NO pstn but maybe would short >239 ? Similar to NVS 👇, a multi-year breakout?
0 · Reply
DDaphne52
DDaphne52 Apr. 21 at 6:32 PM
$JNJ breaking down
0 · Reply
deltax10
deltax10 Apr. 21 at 5:13 PM
$JNJ buy 500 shares at 226, since then going down Officially bag holder 🤣🤣🤣
0 · Reply
RamGuy_949322
RamGuy_949322 Apr. 21 at 4:55 PM
$JNJ good buy here
0 · Reply
TalkMarkets
TalkMarkets Apr. 21 at 4:51 PM
Johnson & Johnson Forecast: Buyers Should Enter Between 227.8 - 215.8 Area $JNJ https://talkmarkets.com/article/johnson-johnson-forecast-buyers-should-enter-between-2278---2158-area-1776790250
0 · Reply
Aporia
Aporia Apr. 21 at 4:28 PM
$JNJ build range now, and consolidate for 4 years?
0 · Reply
mr_Apex
mr_Apex Apr. 21 at 4:23 PM
$JNJ 05/01 220p $2.02 🏌🏽
0 · Reply
Mrhvssss
Mrhvssss Apr. 21 at 4:23 PM
$JNJ 05/01 220P $2.02
0 · Reply
PickAlpha
PickAlpha Apr. 21 at 3:55 PM
3/5: Eli Lilly to buy Kelonia Therapeutics for $3.25B upfront plus milestones (up to $7B total); close expected 2H26 | View: The deal adds oncology optionality… $LLY $JNJ $GILD $XBI $IBB
0 · Reply
Arcides
Arcides Apr. 21 at 3:32 PM
$JNJ that breakdown had follow through...
0 · Reply
yellowstar16
yellowstar16 Apr. 21 at 3:26 PM
$JNJ added. 🛒🛒🛒🛒
0 · Reply
Suite510
Suite510 Apr. 21 at 3:15 PM
$JNJ $SPX $SPY Estimated 30B legacy talc liability, yea but what do I know lol 😂😉
0 · Reply
DragonAlgo
DragonAlgo Apr. 21 at 3:11 PM
🐉 $JNJ PUT — DragonAlgo® Signal Contract: JNJ PUT Expiry: 2026-04-24 | Strike: $227.50 | Type: PUT Option Plan (premium): Entry: $2.90 Stop: $2.08 TP1: $3.76 TP2: $4.92 TP3: $6.95 🔗 https://dragonalgo.com
0 · Reply
Donovanvick
Donovanvick Apr. 21 at 2:56 PM
$JNJ Going all in
0 · Reply
Matth4550
Matth4550 Apr. 21 at 1:49 PM
$JNJ soon under 200$
0 · Reply
thebusthebus
thebusthebus Apr. 21 at 1:15 PM
$MDCX $LLY $GME $JNJ Teverelix is estimated by its developer, Medicus Pharma, to be a combined $6 billion annual market opportunity across its primary urological indications. Market Opportunity Breakdown: Prostate Cancer ($4B+ Market): Targeted toward patients with high cardiovascular risk. Estimates indicate 300,000 to 500,000 men in the U.S. live with advanced prostate cancer, representing a potential $4 billion annual opportunity. Acute Urinary Retention ($2B Market): Aimed at preventing recurrence (AURr) in men with enlarged prostates (BPH). This is positioned as a potential first-in-market pharmacologic therapy for this specific condition, valued at $2 billion.
0 · Reply